SAN FRANCISCO — China’s rapid development is offering great opportunities for overseas hi-tech talents to start their careers and unleash their potential, a Chinese senior executive said Sunday in Silicon Valley.
“More and more overseas Chinese hi-tech talents are showing greater interest in going back to China to start a business, particularly in the field of biology, mainly because of China’s rapid development and its huge population,” said Yongwei Zhang, chief operating officer of a Silicon Valley-based life sciences company.
Biological technology’s ultimate application is in the medical sector and there are more business opportunities in China as it has an enormous population, as well as greater chance of a large number of patients, said Zhang of Complete Genomics, a wholly-owned subsidiary of Beijing Genomics Institute, the world’s largest genomics service company.
Hundreds of Chinese and American representatives from science, investment and academic communities gathered here Sunday to attend the third China-US summit at University of California, Berkeley.
Eric Betzig, the 2014 Nobel Laureate of Chemistry for the development of super-resolved fluorescence microscopy, delivered a keynote speech on the biological development in the past years.
New advances in the past decade will help improve microscopy technology, which is “kind of a forgotten technology in basic biology and drug discovery,” Betzig said.